C-reactive protein, established risk factors and social inequalities in cardiovascular disease - The significance of absolute versus relative measures of disease

BMC Public Health

Volumn 8, Issue , 2008, Pages

  Rosvall, Maria ^a   Engström, Gunnar ^b   Berglund, Göran ^b   Hedblad, Bo ^b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; RISK FACTOR; SEX DIFFERENCE; SOCIOECONOMICS; STROKE; AGED; COHORT ANALYSIS; DIABETES MELLITUS; DYSLIPIDEMIA; EDUCATIONAL STATUS; HOSPITALIZATION; MIDDLE AGED; PREVALENCE; SMOKING; SOCIAL JUSTICE; SWEDEN;

AGED; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS; DYSLIPIDEMIAS; EDUCATIONAL STATUS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SOCIAL JUSTICE; SWEDEN;

EID: 47349116594     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-8-189     Document Type: Article

References (50)

1. Occupational class and cause specific mortality in middle aged men in 11 European countries: comparison of population based studies. EU Working Group on Socioeconomic Inequalities in Health. AE Kunst F Groenhof JP Mackenbach EW Health, BMJ 1998 316 1636 42 9603745
2. Epidemiology and prevention of cardiovascular diseases. A global challenge. D Labarthe, Gaithersburg: Aspen Publishers 1998
3. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. H Tunstall-Pedoe K Kuulasmaa M Mähönen H Tolenen E Ruokoski P Amoyel, Lancet 1999 353 1547 57 10.1016/S0140-6736(99)04021-0 10334252
4. Socioeconomic factors and cardiovascular disease: a review of the literature. GA Kaplan JE Keil, Circulation 1993 88 1973 98 8403348
5. Cardiovascular disease and risk factor epidemiology: a look back at the epidemic of the 20th century. FJ Nieto, Am J Public Health 1999 89 292 94 10076474
6. Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations. M Huisman AE Kunst M Bopp J-K Borgan C Borrell G Costa P Deboosere S Gadeyne M Glickman C Marinacci C Minder E Regidor T Valkonen JP Mackenbach, Lancet 2005 365 493 500 15705459
7. Concepts of interaction. K Rothman S Greenland A Walker, Am J Epidemiol 1980 112 467 70 7424895
8. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. TA Pearson GA Mensah RW Alexander JL Anderson RO Cannon 3rd M Criqui YY Fadl SP Fortmann Y Hong GL Myers N Rifai SC Smith Jr K Taubert RP Tracy F Vinicor Centers for Disease Control and Prevention; American Heart Association, Circulation 2003 107 499 511 10.1161/01.CIR.0000052939.59093.45 12551878
9. The role of low grade inflammation as measured by C-reactive protein levels in the explanation of socioeconomic differences in carotid atherosclerosis. M Rosvall G Engström L Janzon G Berglund B Hedblad, Eur J Public Health 2007 17 340 7 10.1093/eurpub/ckl247 17068002
10. The real contribution of the major risk factors to the coronary epidemics: time to end the "Only-50%" myth. P Magnus R Beaglehole, Arch Intern Med 2001 161 2657 60 10.1001/archinte.161.22.2657 11732929
11. Explaining the social gradient in coronary heart disease: comparing relative and absolute risk approaches. J Lynch G Davey Smith S Harper K Bainbridge, J Epidemiol Community Health 2006 60 436 41 10.1136/jech.2005.041350 16614335
12. The Malmö Diet and Cancer Study. Design and feasibility. G Berglund S Elmståhl L Janzon SA Larsson, J Int Med 1993 223 45 51
13. The Malmö diet and cancer study: representivity, cancer incidence and mortality in participants and non-participants. J Manjer S Carlsson S Elmståhl B Gullberg L Janzon M Lindström I Mattisson G Berglund, Eur J Cancer Prev 2001 10 489 99 10.1097/00008469-200112000-00003 11916347
14. Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmö, Sweden. B Hedblad P Nilsson L Janzon G Berglund, Diabet Med 2000 17 299 307 10.1046/j.1464-5491.2000.00280.x 10821297
15. Occupational status, educational level and the prevalence of carotid atherosclerosis in a general population sample of middle-aged Swedish men and women. Results from the Malmö Diet and Cancer Study. M Rosvall P-O Östergren B Hedblad SO Isacsson L Janzon G Berglund, Am J Epidemiol 2000 152 334 46 10.1093/aje/152.4.334 10968378
16. Treatment of Hyperlipidemia [in Swedish]. Information from the Medical Products Agency in Sweden. 1995 3 178 87
17. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects. M Persson B Hedblad JJ Nelson G Berglund, Arterioscler Thromb Vasc Biol 2007 27 1411 6 10.1161/ATVBAHA.107.142679 17431184
18. Causes of Death 1995. Stockholm: The National Board of Health and Welfare, Centre of Epidemiology. Anonymous, 1997
19. Intra-urban variations in incidence and mortality in myocardial infarction. A study from the myocardial infarction register in the city of Malmö, Sweden. P Tydén O Hansen L Janzon, Eur Heart J 1998 19 1795 1801 10.1053/euhj.1998.1229 9886721
20. World Health Organisation. International Classification of Diseases, Ninth Revision (ICD-9). Geneva: World Health Organisation. 1997
21. Stroke registry in Malmö, Sweden. P Jerntorp G Berglund, Stroke 1992 23 357 61 1542896
22. Epidemiology of stroke in an urban population - aspects of time, place and person. Thesis. FA Khan, Malmö, Lund University, Sweden 2005
23. Blood pressure control and risk of stroke: a population-based prospective cohort study. C Li G Engstrom B Hedblad G Berglund L Janzon, Stroke 2005 36 725 30 10.1161/01.STR.0000158925.12740.87 15746450
24. Rethinking disease: where do we go from here? SL Syme, Ann Epidemiol 1996 6 463 8 10.1016/S1047-2797(96)00097-X 8915479
25. Measuring social inequalities in health - politics or science? G Boström M Rosén, Scand J Public Health 2003 31 211 5 10.1080/14034940210164911 12850975
26. Public Health Report of Sweden (in Swedish). National Board of Health and Welfare, Stockholm, Sweden, The Board 2001
27. Public Health Report of Sweden (in Swedish). National Board of Health and Welfare, Stockholm, Sweden, The Board 1997
28. Socioeconomic differences in risk of myocardial infarction 1971-1994 in Sweden: time trends, relative risks and population attributable risks. J Hallqvist M Lundberg F Diderichsen A Ahlbom, Int J Epidemiol 1998 27 410 5 10.1093/ije/27.3.410 9698128
29. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. J Danesh JG Wheeler GM Hirschfield S Eda G Eiriksdottir A Rumley GD Lowe MB Pepys V Gudnason, N Engl J Med 2004 350 1387 97 10.1056/NEJMoa032804 15070788
30. Predicting cardiovascular risk: so what do we do now? DM Lloyd-Jones L Tian, Arch Intern Med 2006 166 1342 4 10.1001/archinte.166.13.1342 16831997
31. Lifecourse socioeconomic position, C-reactive protein, carotid intima-media thickness in young adults: the cardiovascular risk in Young Finns Study. M Kivimäki DA Lawlor M Jounala G Davey Smith M Elovainio L Keltikangas-Jarvinen J Vahtera JS Viikari OT Raitakari, Arterioscler Thromb Vasc Biol 2005 25 2197 202 10.1161/01.ATV.0000183729.91449.6e 16123322
32. Association between plasma fibrinogen concentration and five socioeconomic indices in the Koupio Ischemic Heart Disease Risk Factor Study. TW Wilson GA Kaplan J Kauhanen RD Cohen M Wu R Salonen JT Salonen, Am J Epidemiol 1993 137 292 300 8452137
33. Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic position. P Jousilahti V Salomaa V Rasi E Vahtera T Palosuo, J Epidemiol Community Health 2003 57 730 3 12933781 10.1136/jech.57.9.730
34. Socioeconomic status, C-reactive protein, immune factors, and responses to acute mental stress. N Owen T Poulton FC Hay V Mohamed-Ali A Steptoe, Brain Behav Immun 2003 17 286 95 10.1016/S0889-1591(03)00058-8 12831831
35. Associations of fibrinogen and C-reactive protein with prevalent and incident coronary heart disease are attenuated by adjustment for confounding factors. British Women's Heart and Health Study. DA Lawlor GD Smith A Rumley GD Lowe S Ebrahim, Thromb Haemost 2005 93 955 63 15886815
36. Occupation, marital status, and low-grade inflammation. Mutual confounding or independent cardiovascular risk factors? G Engstrom B Hedblad M Rosvall L Janzon F Lindgarde, Arterioscler Thromb Vasc Biol 2006 26 643 8 10.1161/01.ATV.0000200100.14612.bb 16357315
37. Socioeconomic status as an independent predictor of physiological biomarkers of cardiovascular disease: evidence from NHANES. P Muennig N Sohler B Mahato, Prev Med 2007 45 35 40 10.1016/j.ypmed.2007.04.005 17521717
38. Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. G Engstrom L Janzon G Berglund P Lind L Stavenow B Hedblad F Lindgarde, Arterioscler Thromb Vasc Biol 2002 22 2054 8 10.1161/01.ATV.0000041842.43905.F3 12482834
39. Inflammation-sensitive plasma proteins are associated with future weight gain. G Engstrom B Hedblad L Stavenow P Lind L Janzon F Lindgarde, Diabetes 2003 52 2097 101 10.2337/diabetes.52.8.2097 12882928
40. Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. G Engstrom B Hedblad KF Eriksson L Janzon F Lindgarde, Diabetes 2005 54 570 5 10.2337/diabetes.54.2.570 15677517
41. Case ascertainment in stroke studies: the risk of selection bias. P Appelros N Högerås A Terent, Acta Neurol Scand 2003 107 145 9 10.1034/j.1600-0404.2003.02120.x 12580866
42. Värdering av diagnoskvaliteten för akut hjärtinfarkt i patientregistret 1987 och 1995. National Board of Health and Welfare, In Swedish
43. Socioeconomic status and health: How education, income and occupation contribute to risk factors for cardiovascular disease. MA Winkleby DE Jatulis E Frank SP Fortmann, Am J Public Health 1992 82 816 20 1585961
44. Socioeconomic position. J Lynch G Kaplan, Social epidemiology Oxford: Oxford University Press, Berkman L, Kawachi I, 2000
45. Socioeconomic differences in myocardial infarction risk. Epidemiological analyses of causes and mechanisms. J Hallqvist, (Thesis) Department of Public Health Sciences, Division of Social Medicine, Stockholm, Sweden 1998
46. The size of mortality differences associated with educational level in nine industrialized countries. AE Kunst JP Mackenbach, Am J Public Health 1994 84 932 7 8203689
47. The role of preclinical atherosclerosis in the explanation of educational differences in incidence of coronary events. M Rosvall G Engström B Hedblad L Janzon G Berglund, Atherosclerosis 2006 187 251 6 10.1016/j. atherosclerosis.2005.08.037 16242699
48. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. DM Vigushin MB Pepys PN Hawkins, J Clin Invest 1993 91 1351 7 8473487 10.1172/JCI116336
49. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. AR Rudnicka A Rumley GD Lowe DP Strachan, Circulation 2007 115 996 1003 10.1161/CIRCULATIONAHA.106. 635169 17296859
50. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. HK Meier-Ewert PM Ridker N Rifai N Price DF Dinges JM Mullington, Clin Chem 2001 47 426 30 11238292